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ABSTRACT 
 
Expression, distribution and cellular localization of sirtuins  
in the normal and ischemic brain of rodent 
 
Jayoung Kim 
 
Department of Medical Science 
The Graduate School, Yonsei University 
 
(Directed by Professor Ji Hoe Heo) 
 
Sirtuins (SIRTs) are nicotinamide adenine dinucleotide-dependent histone deacetylases. To date, seven 
sirtuins (SIRT1-SIRT7) have been identified in mammals. While basic knowledge of sirtuins in the 
brain is essential to understand the role of sirtuins in the normal and pathologic brain, only limited 
information is available. We investigated the distribution and cellular localization of sirtuins in the 
normal and ischemic brain of the rodent. 
Male Sprague-Dawley (SD) rats, Wistar rats, Imprinting Control Region (ICR) mice, and C57BL/6 
mice were used. Normal whole brain samples were obtained. In paraffin or frozen sections, 
immunohistochemistry was performed and the whole brain was examined into regions: olfactory bulb, 
cerebrum and cerebellum. To examine the cell types that express sirtuins, double immunofluorescence 
staining was performed using antibodies for each sirtuin and those for specific cell markers. Cerebral 
ischemia induced by 2 hr of middle cerebral artery occlusion and 22 hr of reperfusion using nylon 
thread. The expression of each sirtuin was compared between normal and ischemic brain areas. 
SIRT1, SIRT3 and SIRT5-7 were expressed in neurons of most of regions and in oligodendrocytes of 
corpus callosum and internal capsule. SIRT2 was expressed in myelin. SIRT4 was expressed in 
vessels. As a result, sirtuins, especially SIRT5-7 were widely distributed and highly expressed in the 
olfactory bulb, cerebrum, and cerebellum. The expression of SIRT1 and SIRT3 in the corpus callosum 
and internal capsule was variable among species. SIRT2 was not expressed in the external plexiform 
layer of olfactory bulb and hypothalamus of cerebrum. SIRT4 was widely expressed in the entire 
brain areas except in the purkinje layer of cerebellum in SD rats. After induction of cerebral ischemia, 
SIRT4 showed significantly increased expression in the ischemic region. However, the other sirtuins 
2 
were not significantly different. 
Distribution and cellular localization in the rodent brain were different among sirtuins. Expression in 
the ischemic brain was also different. Findings of this study might provide with basic information for 
studying pathophysiologic role of sirtuins in the brain. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                                                                                     
Key words : sirtuin, brain, distribution, immunohistochemistry, rodent 
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I. INTRODUCTION 
 
Sirtuins (SIRTs) or Silent information regulator 2 (Sir2) proteins are nicotinamide adenine 
dinucleotide (NAD+) - dependent histone deacetylases. Sirtuins are found from bacteria to 
humans and regulate crucial biological pathways in organisms.1,2 To date, seven sirtuins (SIRT1-
SIRT7) have been identified in mammals. Although sirtuins have similar structural homology, 
their subcellular localizations, enzymatic activities, and biological functions are different. SIRT1, 
SIRT6, and SIRT7 are localized in nucleus, SIRT2 is localized in cytoplasm, and SIRT3 – SIRT5 
are present in mitochondria.3-6 Sirtuins possess predominantly deacetylase activity (SIRT1-SIRT3, 
SIRT7), mono-ADP-ribosyltransferase activity (SIRT4, SIRT6), or desuccinylase and 
demalonylase activities (SIRT5).1,7-9 Given that the subcellular localization (nucleus, cytoplasm, 
or mitochondria) and enzymatic activities (deacetylase or ADP-ribosyltransferase) are different 
among sirtuins, their distribution and cellular expression as well as roles in the brain may be 
different.2,3,5,10 However, most studies have focused on SIRT1 and SIRT2. To understand and 
study the role and function of each sirtuin in the brain, basic knowledge on the cellular and 
anatomical expressions of each sirtuin in the brain is essential. 
 
Sirtuins have been implicated in influencing a wide range of cellular processes including aging, 
transcription, apoptosis, inflammation and stress resistance, as well as energy efficiency and 
alertness during low-calorie conditions.11,12 By virtue of their nature, sirtuins have gained interest 
in aging and longevity, and have been widely studied in the brain diseases such as 
neurodegenerative diseases and cerebral ischemia as a potential therapeutic target.13 Ischemic 
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injury of the brain, which is caused by cessation of blood flow, is mediated by a variety of 
molecular mechanisms. Molecular mediators of cell death or survival of cerebral ischemia have 
been the therapeutic target. Among sirtuins, SIRT1 have been suggested as a potential therapeutic 
target since it is known that the inhibition of SIRT1 abolished resveratrol-induced 
neuroprotection.14 As such, other sirtuins may play roles in ischemic injury. However, the effect 
of sirtuins in ischemic injury and the expression of sirtuins in the ischemic brain have not been 
well known.15,16 
 
Therefore, this study investigated the distributions and cellular localization of each sirtuin in the 
normal brain as well as ischemic brain of the rodent to provide basis for experimental researches 
on sirtuins in the brain. 
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II. MATERIALS AND METHODS 
 
1. Experimental animals 
To examine the distributions and cellular localization of sirtuin in the normal brain, two species 
of male rats and two species of male mice were used. They included nine-week-old Sprague-
Dawley (SD) and Wistar rats, and nine-week-old Imprinting Control Region (ICR) and 
C57BL/6 mice. The care and use of animals were based on the guidelines of the Association for 
Assessment and Accreditation of Laboratory Animal Care (AAALAC) and the protocols 
approved by the Animal Experiment Committee of Yonsei University College of Medicine. 
Rodents were housed with a controlled temperature under 12 hour light/dark cycle with free 
access to food and water. To obtain brain samples, under urethane anesthesia, animals were 
sacrificed through transcardiac perfusion with cold saline. The brain was obtained after 
decapitation. 
 
2. Middle cerebral artery occlusion model and brain sampling 
Cerebral ischemia was induced in SD rats. Animals were anesthetized with isoflurane (5% for 
induction and 2% for maintenance) in a mixture of 70% nitrous oxide and 30% oxygen. During 
operative procedures, body temperature was monitored continuously with a rectal probe and 
maintained at 37.0 ± 0.5℃ using a homeothermic blanket control unit and a heating pad 
(Harvard Apparatus, 507220F). After middle line incision and retraction of muscles, the left 
common carotid artery (CCA) was isolated. After careful dissection of vagus nerve from the 
CCA, CCA, occipital artery and pterygopalatine artery were isolated and ligated using a silk 
suture (B. Braun Medical; 5-0 Silkam®, Rubi, Spain). A commercially available 4-0 fine 
silicon rubber-coated nylon thread (Doccol Co., Sharon, MA, USA) was inserted after 
temporary clipping of the internal carotid artery (ICA) using a vascular clamp (Fine Science 
Tools Inc., 00396-01, North Vancouver, British Columbia, Canada). The suture was introduced 
23 mm or until resistance into the left ICA through the external carotid artery (ECA) to occlude 
the origin of the left middle cerebral artery (MCA). After 2 hr of MCA occlusion (MCAO), 
reperfusion was achieved by removal of the MCAO suture. After 22 hr of reperfusion, the 
animals were sacrificed, and the brain was obtained. 
 
For paraffin blocks, the extracted whole brains were fixed in 4% paraformaldehyde for 
overnight. Fixed brains were then sectioned into 2 mm-thick coronal blocks using a rat/mouse 
brain matrix and embedded in paraffin. For frozen blocks, extracted whole brains were 
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sectioned into 2 mm-thick coronal blocks on ice using the rat/mouse brain matrix, embedded in 
OCT compound (Sakura Fineteck Inc., Torrance, CA, USA), quickly frozen with 2-
methylbutane cooled by dry ice and then stored at -80°C.  
 
3. Immunohistochemical study 
For immunohistochemistry, paraffin tissue sections that were cut into 4 μm-thickness were used. 
Antigen was retrieved IHC-Tek™ epitope retrieval solution and steamer (IHC world, 
Woodstock, MD, USA). After cooling from heat, sections were treated with 0.075% glycine in 
phosphate-buffered saline (PBS) for 10 min and with blotto (Tris-buffered saline containing 
10% horse serum and 1% bovine serum albumin). After incubation with blotto, the sections 
were incubated with the primary antibodies for 2 hr at 37°C (SIRT4 and SIRT6) or overnight at 
4°C (SIRT1 – 3, SIRT5 and SIRT7). The primary antibodies used were rabbit polyclonal anti-
SIRT1 (1:1000, Millipore, 07-131, Temecula, CA, USA), rabbit polyclonal anti-SIRT2 (1:200, 
Sigma-aldrich, S8447, St.Louis, MO, USA), rabbit polyclonal anti-SIRT3 (1:400, Santa Cruz 
biotechnology Inc., sc-99143, Santa Cruz, CA, USA), goat polyclonal anti-SIRT4 (1:200, 
Novus Biological, NB100-1406, Littleton, CO, USA), rabbit polyclonal anti-SIRT5 (1:800, 
Millipore, ABE198), rabbit polyclonal anti-SIRT6 (1:300, Novus Biological, NB100-2522) and 
rabbit polyclonal anti-SIRT7 (1:600, Millipore, ABE103). Sections with blotto lacking primary 
antibodies were used as a negative control. The sections were incubated with the secondary 
antibodies for 30 min at 37° and then, 0.3% hydrogen peroxide in methyl alcohol for 20 min. 
After washing by tap water for 2 min, the sections were treated with an avidin-biotin-
horseradish peroxidase complex (Vector Laboratories Ltd., Peterborough, Cambridgeshire, 
UK) for 30 min to amplify the signals. The signals were visualized by 3,3′-diaminobenzidine 
solution (PBS containing 0.05% 3,3′-diaminobenzidinetetrahydrochloride hydrate and 0.1% 
hydrogen peroxide). After counterstaining with hematoxylin, the slides were mounted with 
permount mounting medium (Fisher Scientific, Fair lawn, NJ, USA). 
 
4. Immunofluorescence staining 
To examine the cell types that express each of sirtuins, brain sections of SD rats were double-
stained with antibodies against each sirtuin and specific cell markers. The staining procedures 
were similar to those in immunohistochemistry, but concentrations of antibodies for some 
sirtuins were slightly changed (1:100 for SIRT3, 1:500 for SIRT5, and 1:100 for SIRT7). The 
antibodies for cell markers used were mouse monoclonal anti-NeuN (1:100, Millipore, 
MAB377) or mouse monoclonal anti-β-tubulin Ⅲ (1:20, Abcam, Ab7751) for neurons, goat 
polyclonal anti- Glial Fibrillary Acidic Protein (GFAP) (1:200, Santa Cruz biotechnology Inc., 
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sc-6170) for astrocytes, mouse anti-collagen type IV (1:100, Developmental studies hybridom 
bank, M3F7, Iowa City, IA, USA) or anti-rat endothelial cell antigen-1 (RECA-1, 1:10, Abcam, 
ab9774, Cambridge, Cambridgeshire, UK) for microvessels, mouse anti-CNPase (1:400, 
Abcam, ab6319) for oligodendrocytes, and mouse monoclonal anti- Myelin basic protein 
(MBP) (1:1000, Covance, SMI-99P, Madison, WI, USA) for myelin. In case of double-staining 
with SIRT4 antibody, rabbit polyclonal anti-GFAP (1:200, Millipore, AB5804) was used. To 
stain the brain tissue with anti-SIRT4 and anti-RECA-1 antibodies, the 10-μm thick frozen 
sections were used. For the remaining staining, paraffin sections were used. To visualize the 
signals, the sections were incubated in FITC-labeled anti-rabbit IgG (Jackson Immunoresearch 
Laboratories, Inc., West Grove, PA, USA) and either Cy3-labeled anti-goat IgG (Jackson 
Immunoresearch Laboratories) or Cy3-labeled anti-mouse IgG (Jackson Immunoresearch 
Laboratories) for 30 min in the dark condition. After the incubation and wash with PBS, the 
sections were mounted in Vectashield Hard Set™ mounting medium with DAPI (Vector 
Laboratories Inc., Burlingame, CA, USA). 
 
5. Examined brain areas for determination of sirtuin expression 
To address the distribution of each sirtuin, whole rodent brains were classified into olfactory 
bulb, cerebrum, and cerebellum. In the olfactory bulb, glomerular layer, external plexiform 
layer, granular cell layer, and anterior olfactory nucleus were identified. Expression of each 
sirtuin in the cerebrum was examined in eight representative regions: cerebral cortex, 
hippocampus, corpus callosum, internal capsule, caudate putamen (striatum), thalamus, 
hypothalamus, and amygdala. In the cerebellum, molecular layer, purkinje cell layer, granular 
layer, and deep cerebellar nuclei were included (Fig. 1). 
8 
 
Figure 1. Representative regions of olfactory bulb, cerebrum, and cerebellum of the rodent 
brain. Gl : Glomerular layer, EPl : Expernal plexiform layer, GrO : Granular cell layer, AO : Anterior 
olfactory nucleus, Ctx : Cerebral cortex, Hip : Hippocampus, CC : Corpus callosum, IC : Internal 
capsule, Cp : Caudate Putamen, T : Thalamus, Hy : Hypothalamus, A : Amygdala, ML : Molecular 
layer, PL : Purkinje cell layer, GL : Granular layer, DN : Deep cerebellar nuclei. Scale bars represent 
500㎛. 
 
6. Analysis 
The consistency of immunostaining was ensured by triplication of experiments by using three 
rats or mice of each species. We investigated whether there is any difference in the expression 
and distribution of sirtuins between the rat and mouse and also among the species. Sections 
were viewed using Axio Imager D2 microscope and Axio Vision software (Carl Zeiss 
MicroImaging GmbH, Jena, Germany) or using LSM700 scanning laser confocal microscope 
and Zen 2011 image software (Carl Zeiss MicroImaging GmbH, Jena, Germany).  
 
To determine the expression pattern of sirutins, we measured and compared cell numbers 
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between ischemic regions and nonishemic regions based on immunohistochemical staining for 
each sirtuins in the brain of SD rats (n=5). The percentage of sirtuin- positive cells were 
estimated by stereological analysis with Stereo investigator software (MBF bioscience, 
Williston, VT, USA) using an optical fractionator. To obtain an unbiased number of positive 
cells of each sirtuin, all contours around ischemic core were traced under 12.5 x magnification. 
Counting frame size was set at 200 x 200 um, and the sampling grid size at 900 x 900um. 
Random placement of the counting frames was accomplished using the motorized stage of 
microscope controlled by the software. The numbers of cells in the counting frame were 
counted at 400 x magnification. Cell density was expressed as the number of cells per unit area 
(mm2). To compare the cell number between ischemic and nonischemic areas, the mean and 
standard error (SE) were calculated and independent-sample t tests were used. Statistical 
analysis was performed using Prism 6 for Windows (Version 6.07, GraphPad Software, Inc., La 
Jolla, CA, USA). P < 0.05 was considered statistically significant. 
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III. RESULTS 
 
1. Distribution of each sirtuin in the brain 
We found that all sirtuins were expressed in the brain of rats and mice. However, their 
distribution was different among sirtuins (Fig. 2). In addition, there were some differences in 
the cellular and anatomical expressions of each sirtuin between species (Table. 1).  
 
 
 
Figure 2. Representative cartoon of each sirtuin in the brain of SD rats. This cartoon shows each 
expression level of sirtuins in the specific regions of olfactory bulb (upper), cerebrum (middle), and 
cerebellum (lower) through sirtuins. Gl : Glomerular layer, EPl : Expernal plexiform layer, Mi : Mitral 
cell layer, GrO : Granular cell layer, IPl : Internal plexiform layer, AO : Anterior olfactory nucleus, 
Ctx : Cerebral cortex, Hip : Hippocampus, CC : Corpus callosum, IC : Internal capsule, Cp : Caudate 
Putamen, T : Thalamus, Hy : Hypothalamus, A : Amygdala, ML : Molecular layer, PL : Purkinje cell 
layer, GL : Granular layer, DN : Deep cerebellar nuclei. 
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Table 1. Expression of sirtuins in the representative regions of the brain in rodents 
  
Sirt1 Sirt2 Sirt3 Sirt4 Sirt5 Sirt6 Sirt7 
Olfactory 
bulb 
Glomerular layer (Gl) + + + + + + + 
External plexiform layer (EPl) 
[including mitral cell layer (Mi)] 
+ +/- + + + + + 
Granular cell layer (GrO) 
[including internal plexiform 
layer (IPl)] 
+ + + + + + + 
Anterior olfactory nucleus (AO) + + +/- + + + + 
Cerebrum 
Cerebral cortex (Ctx) + + + + + + + 
Hippocampus (Hip) + + + + + + + 
Corpus callosum (CC) +/- + +/- + + + + 
Internal capsule (IC) +/- + +/- + + + + 
Caudate Putamen (Cp) + + + + + + + 
Thalamus (T) + + + + + + + 
Hypothalamus (Hy) + +/- + + + + + 
Amygdala (A) + + + + + + + 
Cerebellum 
Molecular layer (ML) + + +/- + + + + 
Purkinje cell layer (PL) + + + +/- + + + 
Granular layer (GL) + + + + + + + 
Deep cerebellar nuclei (DN) + + + + + + + 
+ indicates the presence of signals. +/- means that some species show the signal, but other species do 
not. 
SIRT1 – no detection in the corpus callosum and internal capsule of SD rats and ICR mice  
SIRT2 – no detection in the external plexiform layer of SD rat and in the hypothalamus of ICR mice 
SIRT3 – no detection in the anterior olfactory nucleus of Wistar rats and C57BL/6 mice and in the 
corpus callosum, internal capsule and molecular layer of SD rats 
SIRT4 – no detection in the purkinje cell layer of SD rats 
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SIRT1 
SIRT1 was widely distributed and highly expressed in the olfactory bulb, cerebrum, and 
cerebellum, except for the corpus callosum and internal capsule in all examined rodents. The 
expression was less intense in the deep cerebellar nuclei (Fig. 3). Expression of SIRT1 in the 
corpus callosum and internal capsule showed variation between species in that SIRT1 was 
expressed in Wistar rats and C57BL/6 mice, but not in SD rats and ICR mice.  
 
 
Figure 3. Representative expression pattern of SIRT1 in the brain of SD rats. SIRT1 is expressed 
in the all examined brain regions except for the corpus callosum and internal capsule. Scale bar 
represents 20㎛. 
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SIRT2 
SIRT2 protein was detected in most regions of the olfactory bulb in mice and rats. However, 
SIRT2 was not expressed in the external plexiform layer of SD rats. SIRT2 was expressed in 
the all examined areas of cerebrum and cerebellum except for ICR mice that did not express 
SIRT2 in the hypothalamus (Fig. 4).  
 
 
Figure 4. Representative expression pattern of SIRT2 in the brain of SD rats. Most regions show 
SIRT2-positive signals except for the external plexiform layer of olfactory bulb. Scale bar represents 
20㎛. 
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SIRT3 
SIRT3 was widely distributed in the olfactory bulb. However, SIRT3 was not expressed in 
the anterior olfactory nucleus of Wistar rats and C57BL/6 mice. SIRT3 was widely expressed 
in the all examined areas of the cerebrum and cerebellum in Wistar rats, ICR mice, and 
C57BL/6 mice. However, SIRT3 was not expressed in corpus callosum, internal capsule and 
molecular layer of cerebellum in SD rats (Fig. 5). 
 
 
Figure 5. Representative expression pattern of SIRT3 in the brain of SD rats. SIRT3 was widely 
distributed in the olfactory bulb and the cerebrum. However, SIRT3 was not expressed in corpus 
callosum, internal capsule and molecular later of cerebellum. Scale bar represents 20㎛. 
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SIRT4 
SIRT4 protein could be found in the whole olfactory bulb, cerebrum and cerebellum. 
However, it was hard to find positive signals in the purkinje cell layer of SD rats (Fig. 6). 
 
 
Figure 6. Representative expression pattern of SIRT4 in the brain of SD rats. SIRT4 is detected 
in whole olfactory bulb and cerebrum of the rodent brain. SIRT4 also show positive signals in the 
cerebellum but it is hard to find certain signals in the purkinje cell layer of cerebellum. Scale bar 
represents 20㎛. 
16 
SIRT5 
SIRT5 was weakly expressed in the olfactory bulb when comparing to other sirtuins. As well, 
SIRT5 was sparsely expressed in the glomerular layer. However, SIRT5 was strongly 
expressed in the all examined areas of cerebrum. While SIRT5 was expressed in the entire 
cerebellum, its expression was stronger in the purkinje cell layer and deep cerebellar nuclei 
than in the molecular layer and granular layer (Fig. 7). 
 
 
Figure 7. Representative expression pattern of SIRT5 in the brain of SD rats. SIRT5 was 
expressed in the all examined areas of olfactory bulb, cerebrum and cerebellum. Scale bar represents 
20㎛. 
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SIRT6 
SIRT6 protein showed wide distribution and strong expression throughout the entire regions 
of rodent brain (Fig. 8). 
 
 
Figure 8. Representative expression pattern of SIRT6 in the brain of SD rats. SIRT6 is highly 
expressed in all representative regions of the rodent brain. Scale bar represents 20㎛. 
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SIRT7 
SIRT7 was widely expressed in the olfactory bulb as well as in the all regions of the 
cerebrum and cerebellum with high intensity. (Fig. 9). 
 
 
Figure 9. Representative expression pattern of SIRT7 in the brain of SD rats. SIRT7 is broadly 
distributed in the rodent brain. Most regions show high expression level of SIRT7. Scale bar 
represents 20㎛. 
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2. Cellular localization of each sirtuin  
Cellular localization was determined using dual immunofluorescence staining in the brain of 
SD rats. SIRT1 was co-localized with NeuN-positive cells, which suggests that SIRT1 was 
expressed in neuronal cells (Fig. 10A). SIRT2 was not co-localized with anti-NeuN, anti-
GFAP or anti-Collagen type antibody Ⅳ. Expression pattern of SIRT2 was filamentous-, 
and co-localized with MBP-positive cells, suggesting that SIRT2 was present in myelin (Fig. 
10B). SIRT3 was not co-localized with anti-NeuN but with anti-β-Ⅲ-tubulin antibody that is 
specific for all neurons (Fig. 10C). This finding suggests that SIRT3 was associated with 
neuronal cells. Unique morphology of SIRT4 was verified by staining with anti-collagen type 
Ⅳ or anti-RECA-1. SIRT4 signals were co-localized with collagen type Ⅳ-positive cells 
and RECA-1-positive cells, implying that SIRT4 was expressed in vessels (Fig. 10D). 
 
We also found that NeuN-positive cells were co-expressed with SIRT5-7 proteins (Fig. 11). 
Collagen type Ⅳ-positive cells were co-localized with some SIRT5 proteins (Fig. 11B). 
SIRT5-7 showed some signals in the corpus callosum and internal capsule where neuronal 
cells do not present, and were co-localized with oligodendrocytes on dual staining with 
CNPase antibody (Figure 11D). These findings suggest that SIRT5-7 are expressed in 
neurons and oligodendrocytes. All seven sirtuins were not detectable in GFAP-positive cells, 
which suggest that sirtuins are not expressed in astrocytes (Table. 2).  
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Figure 10. Cellular localization of SIRT1-4 in SD rats. (A) SIRT1 is co-localized with Neuronal 
nuclei (NeuN). (B) SIRT2 is merged with myelin basic protein (MBP). (C) SIRT3 is partially co-
localized with NeuN but mostly with β-tubulin Ⅲ (β-T.Ⅲ). (D) SIRT4 is co-localized with collagen 
type Ⅳ or Rat endothelial cell antigen-1 (RECA-1). SIRT1 and SIRT3 are partially co-localized with 
CNPase. Scale bar represents 20㎛. 
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Figure 11. Cellular localization of SIRT5-7 in SD rats. (A, B) SIRT5 mainly co-localized with 
neuronal cells and partially with collagen type Ⅳ. (C, E) SIRT6 and SIRT7 were mainly expressed in 
neuronal cells. (D) SIRT6 including SIRT5 and SIRT7 partially co-localized with CNPase. Scale bar 
represents 20㎛. 
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Table 2. Examination of co-localization between each sirtuin and specific marker in the brain of 
SD rats 
Cellular localization SIRT1 SIRT2 SIRT3 SIRT4 SIRT5 SIRT6 SIRT7 
* Neuronal cell + - + - + + + 
* Blood vessel - - - + + - - 
Myelin - + - - - - - 
Astrocyte - - - - - - - 
Oligodendrocyte - + - - + + + 
+ : co-localized between each sirtuin and specific marker 
- : not merged between each sirtuin and specific marker 
*Two types of neuronal cell marker were used (NeuN, β-tubulin Ⅲ). Cell markers for blood vessel 
were also two different antibodies (Collagen type Ⅳ, RECA-1). 
Myelin (MBP), Astrocyte (GFAP), Oligodendrocytes (CNPase)  
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3. Expression pattern and cell density of each sirtuin after cerebral ischemia 
The number of cells that express sirtuins in the ischemic area was compared those in the 
corresponding nonischemic area (Fig. 12A). The cell number was counted and compared in 
all sirtuins but SIRT2 that is expressed in myelin. The number of SIRT1, SIRT6, or SIRT7-
positive cells tended to be decreased in the ischemic region. The number of SIRT3 or SIRT5-
positive cells tended to be increased in the ischemic region. Quantification revealed that the 
number of SIRT4-positive cells was significantly higher in the ischemic region than in the 
nonischemic region (P=0.019) (Fig. 12B). 
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Figure 12. Cell density for each sirtuins. Using Stereo investigator program, the number of cells 
were measured based on immunohistochemical staining for each sirtuin. The number of SIRT4 was 
significantly higher in the ischemic region than the nonischemic region (P=0.019) (c). The cell density 
was not significantly different in the other sirtuins (a, b, d, e, f). The cell number could not be counted 
in SIRT2 because it expresses in myelin. 
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IV. DISCUSSION 
 
In this study, we demonstrated that sirtuins are highly and widely expressed in the rodent brain across 
the species/strain at protein levels. However, their expression patterns including regional distribution 
and cellular localization were different among sirtuins. Our findings also suggested that the 
expression of sirtuins were slightly different among each species/strain of the rodent. As such, these 
strain and species-specific differences should be considered for researches using sirtuins in the rodent 
brain. 
 
Rodents have developed olfactory structures unlike human because rodents use scent marking in 
many social contexts. All regions of olfactory structures are highly organized and composed of many 
layers. All sirtuins were detected throughout olfactory bulb of rodents except SIRT2 and SIRT3 that 
showed variation between species. SIRT2 was not expressed in the external plexiform layer of SD rats, 
and SIRT3 was not in the olfactory nucleus of the Wistar rats and C57BL/6 mice. The external 
plexiform layer has important roles in the second level of synaptic processing in the olfactory bulb 
between the glomerular layer and the mitral cell layer. The anterior olfactory nucleus is likely to play 
a central role in olfactory information processing. In this study, sirtuins were strongly expressed in the 
glomerular layer of the olfactory bulb which is an important way station in the pathway from the nose 
to the olfactory cortex and is critical for odorant signal transduction. It suggests that sirtuins might 
contribute to synaptic procession of odor information coming from the nose. 
 
The cerebrum is the largest and most developed part of the brain. Sirtuins were highly expressed in 
the cerebral cortex regions as well as hippocampus, thalamus and hypothalamus of rodent brain. 
Expression of SIRT1 and SIRT3 in the corpus callosum and internal capsule showed variation 
between species. The corpus callosum and internal capsule are large white matter structures in the 
brain. They are composed of axons and glial cells, while neuronal somata make up less than 1%. 
SIRT1 and SIRT3, which were mainly detected in neuronal cells, were also expressed in the corpus 
callosum and internal capsule in Wistar rats and C57BL6 mice.  
 
In this study, in contrast to other rodents, SIRT2 was not detected in the hypothalamus of ICR mice. 
SIRT2 might be involved in maintaining cellular ATP levels.17 Decreased ATP levels in SIRT2 
knock-out mice could lead to activation of the AMPK pathway, which in turn has been shown to 
affect multiple downstream events including hypothalamic inhibition of proopiomelanocortin.18 
However, we could not infer any answer about the absence of SIRT2 in the hypothalamus of ICR 
mice.  
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In case of the cerebellum, all sirtuins were distributed in four representative regions of cerebellum, 
while SIRT3 and SIRT4 were not in the particular regions of SD rats. At the top lies the molecular 
layer, which contains the flattened dendritic trees of Purkinje cells. It shows that molecular layer and 
purkinje cell layer are connected to each other for processing. SIRT3 and SIRT4 protein levels are 
known to have modestly lower expression levels in the cerebellum than other regions such as cortex, 
hippocampus, and striatum of Wistar rat brain.19 This study showed that the diversity of expression 
levels in SIRT 3 and 4 were more variable in SD rats than Wistar rats. Consequently, it was hard to 
find expression of SIRT3 and SIRT4 in the cerebellum of SD rats. Moreover, SIRT3 and SIRT4, the 
mitochondrial sirtuins, may respond to changes in cellular and nutrient stress by modification of 
downstream target proteins.20,21 
 
This study did not investigate the role or function of each sirtuin in the brain. However, the different 
expression pattern of sirtuins in the brain in terms of distribution in the brain, localization in the brain 
cells, and inherent activities suggests the diverse roles of sirtuins in the brain. SIRT1 and SIRT5-7 
were mainly localized in neuronal cells. SIRT1 is known to be ubiquitously expressed across the 
entire rodent brain, and to be predominantly localized in neuronal nuclei, which is consistent with 
findings of this study. SIRT1 has been suggested to promote axonal elongation, neurite outgrowth, 
and dendritic branching. SIRT1 also plays protective roles in several neurodegenerative diseases 
including Alzheimer’s, Parkinson’s, and motor neuron diseases, which may relate to its functions in 
metabolism, stress resistance, and genomic stability.22 SIRT3 mediates the caloric reduction of 
oxidative DNA damage in multiple tissues.23 These findings suggest that SIRT1 and SIRT3 play an 
important role in neuronal health during aging and may thus compromise protection against 
neurodegenerative diseases.  
 
SIRT2 was expressed myelin in this study. SIRT2 is known to present in the cytoplasm of mature 
myelin sheath and Schwann cells,24 which supports our findings. SIRT2 is expressed predominantly in 
oligodendrocytes, the myelin-producing cells of the central nervous system.25 In contrast to other 
sirtuins, SIRT4 was expressed in vessels. SIRT5 was also expressed in vessels. It was known that 
SIRT4 is expressed in all tissues with highest levels in the kidney, heart, brain, and liver.26 The role of 
SIRT4 in the vessels remains unknown. The expression pattern of SIRT5-7 was similar to SIRT1 and 
SIRT3 in that SIRT5-7 were expressed in neurons. SIRT5 localizes to the mitochondrial matrix, but 
also is identified in the intermembrane space. SIRT5 interacts with cytochrome c, a protein linked to 
mitochondrial metabolism and apoptotic signaling.27 However, the significance of SIRT5 activity in 
metabolism is not yet known. The role of SIRT6 in brain function and neuronal survival is largely 
unknown. Nevertheless, SIRT6 may play a role in synaptic function and neuronal maturation and it 
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may be implicated in the regulation of neuronal survival.28 Little is known about the role of SIRT7 in 
brain and neuronal cells. 
 
Of note, no sirtuin was expressed in astrocytes, which are the most abundant cells in the brain. 
Considering that each sirtuin was mainly expressed in one cell type, such as SIRT1, SIRT3, and 
SIRT5-7 in neurons, SIRT in myelin, and SIRT4 in vessels, each sirtuin may serve their specific 
functions in the brain. 
 
We examined the expression pattern of sirtuins after induction of cerebral ischemia, which is one of 
the most severe types of brain injuries. Expressions of SIRT1, SIRT6 and SIRT7 showed decreased 
tendency in the ischemic brain. This is consistent with findings in previous studies.15,16,29 The 
expression of SIRT1 was reduced in ischemic penumbra in the MCAO group. Hyperbaric oxygen 
preconditioning-induced ischemic tolerance against cerebral ischemic injury was associated with 
upregulation of SIRT1, which suggests that to role of SIRT1 against ischemic injury in 
neuroprotection.15 The expression of SIRT6 also tended to be decreased in ischemic areas of the rat 
brain in this study. The levels of SIRT6 in neuron were susceptible to ischemia, and were associated 
with the release of high mobility group box-1 that participates in brain damage.16 Little is known on 
the expression or role of SIRT7 in cerebral ischemia as well as in normal brain. However, SIRT7-
deficient cardiomyocytes were more susceptible to oxidative and genotoxic stress.29 Along with those 
previous studies, our findings suggest that SIRT7 may also have a role in protection during ischemic 
episodes. 
 
In this study, the expressions of SIRT3 and SIRT5 tend to be increased in the ischemic region. 
Furthermore, the expression of SIRT4 was significantly increased in the ischemic area, suggesting 
that seven sirtuins might have different functions positively or negatively for the neuroprotection. 
SIRT4 has tumor-suppressive activity and regulates the cellular metabolic response to DNA damage 
by inhibiting glutamine metabolism.30 Moreover, SIRT4 plays a protective role in hypoxia-induced 
apoptosis in H9c2 cardiomyoblast cells and it might be beneficial in the treatment of ischemic heart 
disease.31 SIRT4 is induced in response to stress. These findings suggest that increase of SIRT4 in 
vessels might be related to the protective response to ischemic injury.30 
 
This present study provided basic information of expression patterns and distributions of all sirtuin 
families in the whole brain of various rodents. This study also suggests that one should be cautious in 
choosing species/strain of rodent and interpreting the result in sirtuin-related researches in the brain 
because there were some differences in the expression pattern between different species/strains of 
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rodent. In addition, the expression was quite different among sirtuins in the ischemic brain. These 
findings suggest the different role of each sirtuin in pathologic conditions in the brain.  
 
V. CONCLUSION 
 
Distribution and cellular localization in the rodent brain were different among sirtuins. Expression in 
the ischemic brain was also different. Findings of this study might provide with basic information for 
studying pathophysiologic role of sirtuins in the brain. 
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ABSTRACT (IN KOREAN) 
 
쥐의 정상 및 허혈 뇌에서의 sirtuin의 발현과 분포 
 
< 지도교수 허지회 > 
 
연세대학교 대학원 의과학과 
 
김 자 영 
 
Sirtuins (SIRTs) 은 니코틴아미드 아데닌 디뉴클레오티드에 의존적인 히스톤 탈아세틸
화 효소이다. 지금까지 SIRT1부터 SIRT7까지 7개의 sirtuins이 알려져 있다. 정상 뇌와 
병리학적인 뇌에서의 sirtuins의 역할을 이해하기 위해서는 뇌에서의 sirtuins의 해부학
적 위치와 세포 내 발현에 대한 기본적인 지식이 필요하다. 그럼에도 불구하고 단지 제
한된 정보만 존재해왔다. 우리는 설치류의 정상 뇌와 허혈성 뇌에서 sirtuins의 세포 내 
위치와 분포를 알아보았다. 
 
Sprague-Dawley (SD) 흰쥐, Wistar 흰쥐, Imprinting Control Region (ICR) 쥐, 그리고 
C57BL/6 쥐를 사용했다. 정상 뇌의 전체 표본은 마취한 상태에서 심장 관류를 통해 얻었
다. 뇌경색은 나일론 사를 이용하여 2시간 동안의 중대뇌동맥 폐색과 22시간의 재관류를 
통해 유도된다. 파라핀이나 동결 절편은 면역조직화학법을 진행했고 전체 뇌는 크게, 후 
신경구, 대뇌, 소뇌로 나누어 관찰하였다. Sirtuins을 발현하는 세포 타입을 알기 위해 
각 sirtuin과 특정 세포 마커인 항체로 이중 형광 염색했다. 신경세포에는 NeuN이나 β-
III tubulin, 수초에는 미엘린 기본 단백질 (MBP), 희돌기교세포에는 CNPase, 성상세포
에는 아교 섬유 산성 단백질 (GFAP), 그리고 혈관에는 collagen type IV나 RECA-1를 사
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용하였다. 
 
SIRT1, SIRT3 그리고 SIRT5-7 은 대부분의 부위의 신경세포에서 발현되었고 뇌량과 내포
의 희돌기교세포에서도 발현되었다. SIRT2는 수초에서 발현되었고 SIRT4는 혈관에서 발
현되었다. 결과적으로, SIRT5 – 7 는 후 신경구, 대뇌, 그리고 소뇌에 걸쳐 넓게 분포하
고 높게 발현되었다. SIRT1 과 SIRT3 는 뇌량과 내포에서 종에 따라서는 발현을 보기 힘
들었다. SIRT2는 설치류 뇌의 대부분의 부위에서 높게 발현됐지만, 후 신경구의 외부층
상층과 대뇌의 시상하부에서는 그렇지 않았다. SIRT3 역시 폭넓게 분포했지만 후 신경구
의 전방 후각 핵과 소뇌의 분자 층에서는 발현 정도가 인식하기에 충분치 않았다. SIRT4 
는 소뇌의 퍼킨지 층을 제외하고는 전체 뇌에 넓게 분포했다. SIRT5 – 7 은 선택한 모든 
부위에서 전체적으로 발현되었다. 뇌경색을 유도한 후에는, SIRT4 의 경우 뇌경색이 온 
부위에서 상당히 증가된 발현을 보였다. 하지만, 다른 sirtuin들은 크게 다르지 않았다. 
 
설치류의 뇌에서의 분포와 세포 내 위치는 각각의 sirtuins 마다 다르게 나타났다. 허혈
성 뇌에서의 발현 또한 달랐다. 이러한 연구는 sirtuins이 뇌에서의 병리학적 역할을 연
구하는 데 있어서 기본적인 정보를 제공할 것이다. 
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